Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial

3Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study aimed to illustrate how a new methodology to assess clinical trial outcome measures using a longitudinal item response theory–based model (IRM) could serve as an alternative to mixed model repeated measures (MMRM). Data from the EXACT (Exacerbation of chronic pulmonary disease tool) which is used to capture frequency, severity, and duration of exacerbations in COPD were analyzed using an IRM. The IRM included a graded response model characterizing item parameters and functions describing symptom-time course. Total scores were simulated (month 12) using uncertainty in parameter estimates. The 50th (2.5th, 97.5th) percentiles of the resulting simulated differences in average total score (drug minus placebo) represented the estimated drug effect (95%CI), which was compared with published MMRM results. Furthermore, differences in sample size, sensitivity, specificity, and type I and II errors between approaches were explored. Patients received either oral danirixin 75 mg twice daily (n = 45) or placebo (n = 48) on top of standard of care over 52 weeks. A step function best described the COPD symptoms-time course in both trial arms. The IRM improved precision of the estimated drug effect compared to MMRM, resulting in a sample size of 2.5 times larger for the MMRM analysis to achieve the IRM precision. The IRM showed a higher probability of a positive predictive value (34%) than MMRM (22%). An item model–based analysis data gave more precise estimates of drug effect than MMRM analysis for the same endpoint in this one case study.

References Powered by Scopus

pROC: An open-source package for R and S+ to analyze and compare ROC curves

8744Citations
N/AReaders
Get full text

When and how should multiple imputation be used for handling missing data in randomised clinical trials - A practical guide with flowcharts

1710Citations
N/AReaders
Get full text

Xpose - An S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

910Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients

2Citations
N/AReaders
Get full text

Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models

1Citations
N/AReaders
Get full text

Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Llanos-Paez, C., Ambery, C., Yang, S., Tabberer, M., Beerahee, M., Plan, E. L., & Karlsson, M. O. (2021). Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial. AAPS Journal, 23(4). https://doi.org/10.1208/s12248-021-00600-1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Researcher 3

25%

Professor / Associate Prof. 1

8%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

44%

Nursing and Health Professions 6

38%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Computer Science 1

6%

Save time finding and organizing research with Mendeley

Sign up for free